On Invalid Date, Acelyrin (NASDAQ: SLRN) reported Q4 2023 earnings per share (EPS) of -$0.75, up 92.45% year over year. Total Acelyrin earnings for the quarter were -$95.21 million. In the same quarter last year, Acelyrin's earnings per share (EPS) was -$9.93.
As of Q2 2024, Acelyrin's earnings has grown year over year. Acelyrin's earnings in the past year totalled -$381.64 million.
What was SLRN's revenue last quarter?
On Invalid Date, Acelyrin (NASDAQ: SLRN) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Acelyrin's revenue was $0.00.
What was SLRN's revenue growth in the past year?
As of Q2 2024, Acelyrin's revenue has grown null year over year. Acelyrin's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.